Eplerenone dosage forms and strengths

Revision as of 22:10, 28 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Eplerenone}} {{CMG}}; {{AE}} {{SS}} ==Dosage Forms and Strengths== *25 mg tablets: yellow diamond biconvex film-coated tablets debossed with Pfizer on one side a...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Eplerenone
INSPRA® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Eplerenone
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Dosage Forms and Strengths

  • 25 mg tablets: yellow diamond biconvex film-coated tablets debossed with Pfizer on one side and NSR over 25 on the other
  • 50 mg tablets: yellow diamond biconvex film-coated tablets debossed with Pfizer on one side and NSR over 50 on the other[1]

References

  1. ↑ "INSPRA (EPLERENONE) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]". Retrieved 28 February 2014.
Retrieved from "https://www.wikidoc.org/index.php?title=Eplerenone_dosage_forms_and_strengths&oldid=949334"